The Rockefeller University HospitalOver 100 Years of Bridging Science and Medicine
On October 26, 1910, the new Rockefeller Institute Hospital admitted its first research participant, opening up a new era of biomedical investigation in which physicians were given the resources and encouragement to engage in fundamental studies in the hospital laboratories of the disease problems they dealt with on the hospital wards. Today, the Hospital’s 100-plus year history can be judged a remarkable success. The interchange between laboratory and clinic has truly been a two-way street, with benefits in both directions.
Development of an Anti-CD27 Agonist Antibody for Immunotherapy of Cancer
Date: Wednesday, December 11, 2013
Time: 12:00 p.m. - 1:00 p.m.
Location: 301 WRB
Speaker: Tibor Keler, Ph.D., senior vice president and chief scientific officer, Celldex Therapeutics, Inc.